Could long-term obesity drug use hurt the food industry?

Now here’s some forward thinking about the complex ramifications for the food industry from the popular and promising new drug regimes for treating obestiy….

CNBC in the US interviewed Pam Kaufman, an equity research analyst at Morgan Stanley, to discuss the impact of obesity drugs on the food and beverage sector.

She elaborates on what companies might be hurt by a possible pullback in appetite brought on by obesity drug use and what food companies could benefit or be disadvantaged from a shift in consumer eating habits.

View the interview here:

Source: CNBC